Guillem Jorba

Targeting autophagy in disease: established and new strategies

Muhammed Koçak, Saba Ezazi Erdi, Guillem Jorba et al. · Autophagy · 2021 · 223 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

In-silico simulated prototype-patients using TPMS technology to study a potential adverse effect of sacubitril and valsartan

Guillem Jorba, Joaquim Aguirre‐Plans, Valentin Junet et al. · PLoS ONE · 2020 · 44 citations · Full text

Life Sciences, Pharmacology, Systems Biology +16

Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an <i>in silico</i> systems biology-based approach

Enric Carcereny, Alonso Fernández-Nistal, Araceli López et al. · Oncotarget · 2021 · 24 citations · Full text

Medicine, Bioinformatics, Oncology +16

Methods to Develop an in silico Clinical Trial: Computational Head-to-Head Comparison of Lisdexamfetamine and Methylphenidate

José Ramón Gutiérrez-Casares, Javier Quintero, Guillem Jorba et al. · Frontiers in Psychiatry · 2021 · 21 citations · Full text

Pharmacy, Pharmacology, Systems Biology +15

Comprehensive detection and characterization of human druggable pockets through binding site descriptors

Arnau Comajuncosa-Creus, Guillem Jorba, Xavier Barril et al. · Nature Communications · 2024 · 18 citations · Full text

Pharmacy, Bioinformatics, Medicinal Chemistry +17